Skip to content
  1. Home
  2. Latest news
  3. Health & wellness
  4. Psyched about the eclipse? What you need to know to protect your eyes and watch it safely

Psyched about the eclipse? What you need to know to protect your eyes and watch it safely

On August 21, the U.S. will witness the first total eclipse of the sun in 40 years. In this video, get tips from a Johnson & Johnson expert on how to safeguard your eyes—and enjoy the one-of-a-kind celestial event.

On Monday, August 21, a total eclipse of the sun will be visible in parts of the continental U.S. for the first time in almost 40 years as the moon completely covers it—and observers in all states will experience at least a partial eclipse.

Because this phenomenon is so rare—the next total eclipse won’t occur in the U.S. until 2024—Americans across the country are clamoring to watch. And there’s no reason not to—as long as you do so safely: Even when blocked by the moon, the sun’s rays, both visible and invisible, can cause severe and permanent damage to the eyes.

So before you check out the eclipse, check out this video—featuring safe viewing tips from Johnson & Johnson Vision ultraviolet expert Cristina Schnider, O.D.


1775614113001-5544058705001-5544061612001-vs.jpg
Eclipse_v6

More from Johnson & Johnson

Terra Kremer, Ph.D., is on a mission to create self-sterilizing surgical tools

Since its launch, Johnson & Johnson has focused on helping make surgeries safer. Learn how this analytical microbiologist and her team are continuing in that tradition with a digital app that aims to change the way medical devices are designed and sterilized.

What is lupus?

Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.

This scientist develops targeted treatments for cancer—here’s what drives and inspires him

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.